Sponsor
Maxine Dexter
Representative · D-OR
Representative · D-OR
The bill increases consumer safety and market transparency by creating a searchable dietary supplement product database and requiring detailed listings, at the cost of added compliance burdens and proprietary exposure for small firms and additional federal spending.
Consumers gain a searchable federal database with unique product listing numbers and required label/ingredient details, improving transparency, helping detect misleading or unsafe supplements, and enabling faster, more targeted recalls and enforcement.
Provides dedicated funding ($7.87M FY2026; $6.615M annually FY2027–2030) to staff the FDA and implement the database, supporting timely rollout and ongoing maintenance of the system.
Small manufacturers and distributors must bear new compliance costs and administrative burdens to prepare and submit product listings and respond to 5-day information requests.
Products that fail to list or keep information updated are deemed misbranded, exposing noncompliant firms to enforcement actions and possible removal from the market.
The public database may disclose sensitive business information (labels, formulations) with limited FOIA protections, creating competitive and proprietary risks for firms.
Based on analysis of 2 sections of legislative text.
Requires a mandatory federal listing and public searchable database for all dietary supplements sold in the U.S., with FDA-issued product listing numbers and reporting rules.
Official title: To improve transparency and the availability of information regarding dietary supplements by amending the Federal Food, Drug, and Cosmetic Act to require manufacturers of dietary supplements to list dietary supplements with the Food and Drug Administration.
Introduced April 20, 2026 by Maxine Dexter · Last progress April 20, 2026
Creates a federal requirement that all dietary supplements marketed in the United States be registered in a public, searchable database with assigned product listing numbers and required product and facility information. The Food and Drug Administration (the Secretary) must provide product listing numbers and launch the public electronic database within two years, and failure to list or respond to information requests would be treated as misbranding. The law permits electronic submissions, requires a U.S. agent for foreign firms, authorizes specific funding for implementation and staffing, protects certain proprietary information from public disclosure, and allows the FDA to reserve and assign listing numbers and request additional facility/source addresses with short response deadlines.